Search
- Cost Estimate
As reported by the House Committee on Transportation and Infrastructure on May 8, 2024
- Cost Estimate
As ordered reported by the House Committee on Homeland Security on April 10, 2024
- Report
Eric J. Labs, an analyst in CBO’s National Security Division, testifies before the House Homeland Security Committee's Subcommittee on Transportation and Maritime Security on May 7, 2024.
- Presentation
Presentation by Tamara Hayford, CBO’s Deputy Director of Health Analysis, to the Members’ Roundtable of No Patient Left Behind.
- Report
Compared with private-sector employees, the average compensation costs for federal employees in 2022 were greater among workers whose education culminated in a bachelor’s degree or less, but lower among workers with more education.
- Presentation
Presentation by Phillip Swagel, CBO’s Director, at a conference organized by the Economic Policy Innovation Center and the Paragon Health Institute.
- Report
CBO summarizes recent research findings about Medicare accountable care organizations and the factors that have contributed to or limited their ability to achieve net budgetary savings for the Medicare program.
- Report
The Subcommittee on Health of the House Committee on Energy and Commerce convened a hearing at which Chapin White, CBO’s Director of Health Analysis, testified. This document provides CBO’s answers to questions submitted for the record.
- Report
The House Committee on the Budget convened a hearing at which Phillip L. Swagel, CBO's Director, testified. This document provides CBO’s answers to questions submitted for the record.
- Report
CBO expects to be able to provide an estimated range of the budgetary effects of H.R. 1770, the Equitable Community Access to Pharmacist Services Act, by the end of June 2024.